Name | Description | Size | Catalog # | |
---|---|---|---|---|
Ephrin B1 (EFNB1) Human Over-expression Lysate | EFNB1 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1378142 | More Info |
Ephrin B1 (EFNB1) Human Over-expression Lysate | Transient overexpression lysate of ephrin-B1 (EFNB1) | 100 ug | orb1357807 | More Info |
Ephrin B2 (EFNB2) Human Over-expression Lysate | EFNB2 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1366196 | More Info |
Ephrin B2 (EFNB2) Human Over-expression Lysate | Transient overexpression lysate of ephrin-B2 (EFNB2) | 100 ug | orb1345856 | More Info |
Ephrin B1/2 peptide | The peptide is used to Ephrin B1 / 2 antibody ractivity. Purity > 85%. | 5 mg, 1 mg | orb304983 | More Info |
Ephrin B1 Recombinant Protein | Ephrin B1 Recombinant Protein. Purity > 95% as determined by SDS-PAGE. MW:… | 0.2 mg | orb1228078 | More Info |
Ephrin-B1 Recombinant Protein | Ephrin-B1 Recombinant Protein. Purity >95% as determined by reducing SDS-P… | 0.05 mg | orb1229081 | More Info |
Ephrin-B1 Recombinant Protein | Ephrin-B1 Recombinant Protein. Purity >95% as determined by reducing SDS-P… | 0.05 mg | orb1228532 | More Info |
Ephrin-B2 Recombinant Protein | Ephrin-B2 Recombinant Protein. Purity >95% as determined by reducing SDS-P… | 0.05 mg | orb1229463 | More Info |
Ephrin-B2 Recombinant Protein | Ephrin-B2 Recombinant Protein. Purity >95% as determined by reducing SDS-P… | 0.05 mg | orb1228981 | More Info |
Ephrin type-A receptor 3 | n/a | 50 ug, 100 ug, 1 mg | orb1642196 | More Info |
Ephrin type-A receptor 3 | n/a | 100 ug, 1 mg, 50 ug | orb1641855 | More Info |
Ephrin type-A receptor 4 | n/a | 100 ug, 1 mg, 50 ug | orb1641825 | More Info |
Ephrin type-A receptor 4 | n/a | 50 ug, 100 ug, 1 mg | orb1641965 | More Info |
Ephrin type-A receptor 4 Recombinant Protein | Ephrin type-A receptor 4 Recombinant Protein. Purity >95% as determined by… | 0.05 mg | orb1228422 | More Info |
Ephrin Type-A Receptor 7 Recombinant Protein | Ephrin Type-A Receptor 7 Recombinant Protein. Purity >95% as determined by… | 0.05 mg | orb1229414 | More Info |
Ephrin type-B receptor 4 | n/a | 50 ug, 100 ug, 1 mg | orb1641984 | More Info |
Ephrin type B receptor 2 Recombinant Protein | Ephrin type B receptor 2 Recombinant Protein. Purity >95% as determined by… | 0.05 mg | orb1228490 | More Info |
Ephrin Type-B Receptor 1 Recombinant Protein | Ephrin Type-B Receptor 1 Recombinant Protein. Purity >95% as determined by… | 0.05 mg | orb1229236 | More Info |
Ephrin Type-B Receptor 1 Recombinant Protein | Ephrin Type-B Receptor 1 Recombinant Protein. Purity >95% as determined by… | 0.05 mg | orb1229035 | More Info |
EP300 Human Over-expression Lysate | EP300 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1364879 | More Info |
EP300 Human Over-expression Lysate | Transient overexpression lysate of E1A binding Protein p300 (EP300) | 100 ug | orb1344539 | More Info |
EPHX1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb596127 | More Info |
EPHX2 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb596128 | More Info |
EPHX2 Human Over-expression Lysate | EPHX2 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1365128 | More Info |
EPHX2 Human Over-expression Lysate | Transient overexpression lysate of epoxide hydrolase 2, cytoplasmic (EPHX2) | 100 ug | orb1344788 | More Info |
EPHX2 Immunizing peptide | n/a | 100 ug | orb738128 | More Info |
EPHX2 Peptide | n/a | 0.1 mg | orb1234742 | More Info |
EPHX3 peptide | The peptide is used to block anti-ABHD9 antibody reactivity. Purity > 85%. | 5 mg, 1 mg | orb218649 | More Info |
EPHX1 siRNA (Human) | siRNA to inhibit EPHX1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866829 | More Info |
EPHX2 siRNA (Human) | siRNA to inhibit EPHX2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1866828 | More Info |
EPHX3 siRNA (Human) | siRNA to inhibit EPHX3 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1855644 | More Info |
EPHX4 siRNA (Human) | siRNA to inhibit EPHX4 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1851624 | More Info |
EPHX1 siRNA (Mouse) | siRNA to inhibit EPHX1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1848061 | More Info |
EPHX2 siRNA (Mouse) | siRNA to inhibit EPHX2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1848060 | More Info |
EPHX3 siRNA (Mouse) | siRNA to inhibit EPHX3 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1840672 | More Info |
EPHX4 siRNA (Mouse) | siRNA to inhibit EPHX4 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1834341 | More Info |
EPHX1 siRNA (Rat) | siRNA to inhibit EPHX1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1833339 | More Info |
EPHX2 siRNA (Rat) | siRNA to inhibit EPHX2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1831894 | More Info |
EPI-001 | EPI-001 is an androgen receptor N-terminal domain antagonist with IC50 of… | 10 mM * 1 mL in DMSO, 1 g, 250 mg, 100 mg | orb341769 | More Info |
EPI-001 | Purity 99.00%. MW: 394.89 | 500 mg, 10 mg, 50 mg, 200 mg, 100 mg, 25 mg, 5 mg | orb1300428 | More Info |
EPI-001 | n/a | 10 mg, 25 mg, 50 mg | orb1892616 | More Info |
EPI-7170 | Purity 98.00%. MW: 540.88 | 100 mg, 50 mg, 5 mg | orb1686225 | More Info |
(-)-Epiafzelechin | MW: 274.272 | 2 mg | orb1479536 | More Info |
(-)-Epiafzelechin | Purity > 98%. MW: 274.3 | 5 mg, 10 mg | orb1104719 | More Info |
(-)-Epiafzelechin | Purity 98.5% (HPLC). | 25 mg, 10 mg | orb1176511 | More Info |
Epiafzelechin-(2beta-O->7,4beta->8)-ent-epicatechin | Purity ≥98%. MW: 560.5 | 5 mg | orb1736075 | More Info |
(-)-Epiafzelechin 3-O-gallate | Purity > 98%. MW: 426.4 | 5 mg | orb558454 | More Info |
(-)-10-epi-α-Cyperone | Purity 95.0% (HPLC). | 0.02 ml | orb1176385 | More Info |
4-Epialyxialactone | Purity > 98%. MW: 200.2 | 5 mg | orb1105108 | More Info |
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558